Provided by Tiger Trade Technology Pte. Ltd.

Ironwood Pharmaceuticals

4.29
+0.15003.62%
Pre-market: 4.290.00000.00%07:31 EDT
Volume:2.27M
Turnover:9.70M
Market Cap:706.19M
PE:5.44
High:4.30
Open:4.22
Low:4.19
Close:4.14
52wk High:5.78
52wk Low:1.01
Shares:164.61M
Float Shares:136.00M
Volume Ratio:1.41
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7890
EPS(LYR):0.1484
ROE:-574.72%
ROA:47.02%
PB:-4.36
PE(LYR):28.91

Loading ...

Ironwood Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview

Reuters
·
May 05

Ironwood survey finds SBS clinicians prioritize fewer TPN days in future therapies

Reuters
·
May 04

Ironwood Pharmaceuticals to host first-quarter investor update call and webcast

Reuters
·
May 01

Ironwood to present long-term STARS trial safety data for apraglutide in SBS-IF

Reuters
·
Apr 23

Craig-Hallum Sticks to Its Buy Rating for Ironwood Pharma (IRWD)

TIPRANKS
·
Mar 19

Ironwood Pharmaceuticals director Alexander J. Denner disposes of shares worth USD 20.53 million

Reuters
·
Mar 18

BRIEF-Ironwood Pharmaceuticals Satisfies Liquidity Conditions In Credit Agreement On March 10

Reuters
·
Mar 11

Ironwood Pharmaceuticals Inc - Maturity Date for Revolving Credit Facility Remains December 31, 2028 - SEC Filing

THOMSON REUTERS
·
Mar 11

Ironwood Pharmaceuticals extends revolving credit facility maturity to Dec. 31, 2028

Reuters
·
Mar 11

Ironwood Pharmaceuticals to Join Fireside Chat at The Citizens Life Sciences Conference

Reuters
·
Mar 05

Ironwood Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
Feb 26

Ironwood Pharmaceuticals Balances Growth Plans With Pricing Risks

TIPRANKS
·
Feb 26

Ironwood Pharmaceuticals Q4 Adj. EPS $(0.01) Misses $0.01 Estimate, Sales $47.709M Miss $50.933M Estimate

Benzinga Earnings
·
Feb 25

BRIEF-Ironwood Pharmaceuticals Q4 Revenue USD 47.709 Million

Reuters
·
Feb 25

Ironwood Pharmaceuticals Inc: Reiterates 2026 Outlook

THOMSON REUTERS
·
Feb 25

Ironwood Pharmaceuticals Q4 Adjusted Net Income USD -2.274 Million

THOMSON REUTERS
·
Feb 25

Ironwood Pharmaceuticals Q4 Basic EPS USD -0.01

THOMSON REUTERS
·
Feb 25

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook

THOMSON REUTERS
·
Feb 25

Ironwood Pharmaceuticals Inc expected to post earnings of 1 cent a share - Earnings Preview

Reuters
·
Feb 23

Ironwood Pharmaceuticals Inc. published an update to their financial calendar

Reuters
·
Feb 19